Shandong Weigao Group Medical Polymer Company Limited (SEHK: 1066)
Health Care · Health Care Equipment & Supplies · CN
HK$3.31
+1.53% today · -45.4% 1Y
Shandong Weigao Group Medical Polymer Company Limited (SEHK: 1066) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $1.91B and employs 13,310 people.
Over the last twelve months the share price has lost 45.4%, trading between 2.92 and 6.30.
Tweenvest scores Shandong Weigao Group Medical Polymer Company Limited across four factors: quality 72/100, value 89/100, growth 13/100, dividend 50/100. Its strongest factor is value.
1066 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.91B
- Revenue (TTM)
- $2.00B
- P/E
- 9.56
- EPS
- 0.30
- Dividend yield
- 5.63%
- Beta (5Y)
- 0.38
- 52-week high
- HK$6.30
- 52-week low
- HK$2.92
- Avg volume (3M)
- —
- Shares outstanding
- 4.54B
- Employees
- 13,310
- Next earnings
- —
About Shandong Weigao Group Medical Polymer Company Limited
Shandong Weigao Group Medical Polymer Company Limited, founded in 2000 and situated in Weihai, People's Republic of China, specializes in the research, development, production, and distribution of disposable medical devices across mainland China. The company structures its extensive operations into several core divisions, including Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and other specialized segments. Its comprehensive product range covers a vast array of essential healthcare items. This includes devices for both vascular and non-vascular access, such as infusion sets, syringes, and specialized puncture needles, alongside various clinical collection kits. Shandong Weigao also provides solutions for wound care, offering sutures, healing dressings, cleaning products, and support devices for non-vascular catheters. In the realm of blood management, it supplies equipment for collection, storage, separation, and sterilization. The company is also a manufacturer of prefilled and pre-flush syringes, as well as instruments for blood collection and glucose monitoring. Its portfolio further extends to anesthesia consumables (general, local, and auxiliary), intensive care unit (ICU) equipment, and tools for both open and minimally invasive surgical procedures. Beyond disposables, the firm is a key producer of orthopedic devices, instruments for tumor and blood vessel interventions, and advanced medical components such as implantation materials and artificial organs. It also ventures into industrial manufacturing, producing medical-grade PVC granules, various plastic packaging materials, carton boxes, automated industrial equipment and parts, molds, and hemodialysis machines, encompassing Type I, Type II, and Type III medical devices. In addition to its manufacturing activities, Shandong Weigao offers a range of supporting services. These include finance leasing and factoring, wholesale distribution of Type I, surgical, and other disposable medical products. The company also provides asset management, enterprise consulting, management advisory, and comprehensive logistics and storage solutions, while actively exporting its products to international markets. Operating under recognized brands like Jierui, Wego Ortho, Yahua, Bangde, and Hai Xing, the company serves a diverse clientele that includes hospitals, blood banks, various other medical facilities, and a broad network of distributors.
- ISIN
- CNE100000171
- Founded
- 1988
- Listed since
- Feb 27, 2004
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Drägerwerk AG & Co. KGaAXTRA: DRW3 | $2.15B | €115.20 | -1.20% |
| Axogen, Inc.NasdaqCM: AXGN | $2.12B | $35.93 | -0.55% |
| Inspire Medical Systems, Inc.NYSE: INSP | $1.99B | $71.57 | +3.89% |
| Fukuda Denshi Co., Ltd.TSE: 6960 | $1.91B | ¥11,220.00 | -3.53% |
| Shandong Weigao Blood Purification Products Co., Ltd.SHSE: 603014 | $1.90B | CN¥30.45 | -1.10% |
| Vimian Group AB (publ)OM: VIMIAN | $1.90B | Skr35.95 | +0.56% |
| Cofoe Medical Technology Co.,Ltd.SZSE: 301087 | $1.89B | CN¥59.93 | +15.03% |
| Insight Lifetech Co., Ltd.SHSE: 688712 | $1.89B | CN¥30.30 | -2.01% |
Figures last refreshed Oct 11, 2026.